Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Jacobs (United States) · Clifford Chance · +2 more institutions
Abstract
One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cholesterol of 55% to 60% at the maximum dosage, and 6 of the 7 marketed statins are available in generic form, which makes them affordable for most patients. Primarily using data from randomized controlled trials, supplemented with observational data where necessary, this scientific statement provides a comprehensive review of statin safety and tolerability. The review covers the general patient population, as well as demographic subgroups, including the elderly,…
Citation impact
- FWCI
- 80.19
- Percentile
- 100%
- References
- 372
Authors
15Topics & keywords
- Medicine
- Statin
- Stroke (engine)
- Population
- Internal medicine
- Diabetes mellitus
- Myocardial infarction
- Surgery
- Good health and well-being